Calendar Genexine, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
7,040 ^KRW	-1.54%		-5.50%	-28.89%

2023	Genexine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Genexine, Inc. and PT Kalbe Genexine Biologics Receives the First Market Approval for Novel Long-Acting Erythropoietin, Efepoetin Alfa, from the Indonesian Food and Drug Authority	CI

ca377bba2cfe.652k56IEu5GI07-VmnxPSRoGDJLBJ6eDUVeFuSoRnOU.hc3Q1f00_dm8v-Wgyg0qPCNeZvO4XvLaZh_TzGha9JSu7OGu6kL5376ihw~0a4b54a6a21bcf474611a402d9f753cc

2024-05-12	Q1 2024 Earnings Release (Projected)
2024-08-12	Q2 2024 Earnings Release (Projected)
2024-11-12	Q3 2024 Earnings Release (Projected)
2025-05-18	Q1 2025 Earnings Release (Projected)

2024-03-27	Shareholders Meeting
2024-03-12	Q4 2023 Earnings Release
2023-11-13	Q3 2023 Earnings Release
2023-06-05 02:15 pm	American Society of Clinical Oncology Conference - Abstract No 6075
2023-05-14	Q1 2023 Earnings Release
2023-03-19	Q4 2022 Earnings Release
2023-02-05	BIO CEO & Investor Conference
2023-01-08	JP Morgan Healthcare Conference
2022-11-13	Q3 2022 Earnings Release
2022-09-10 02:35 am	European Society for Medical Oncology Congress
2022-08-15	Interim 2022 Earnings Release
2022-05-24 07:00 am	H.C. Wainwright Global Investment Conference
2022-05-15	Q1 2022 Earnings Release
2021-08-16	Interim 2021 Earnings Release
2021-05-16	Q1 2021 Earnings Release
2021-03-18	FY 2020 Earnings Release
2020-03-29	FY 2019 Earnings Release
2019-11-13	Q3 2019 Earnings Release
2019-09-08	Morgan Stanley Global Health Care Conference
2019-05-13	Q1 2019 Earnings Release

Fiscal Period	December	2019	2020	2021	2022	2023
Net sales Billions KRW	Released Forecast Spread	11,3 16,0 -29.39%	18,5 18,4 0.6%	0,00	0,47	3,87
EBITDA Billions KRW	Released Forecast Spread	-42,0 -33,8 -24.51%	-36,2 -31,1 -16.55%	0,00	0,00	0,00
EBIT Billions KRW	Released Forecast Spread	-44,5 -36,9 -20.53%	-39,2 -35,2 -11.31%	0,00	-10,6	-40,5
Earnings before Tax (EBT) Billions KRW	Released Forecast Spread	0,00 0,00 -	27,5 -43,4 163.45%	0,00	-16,9	-39,1
Net income Billions KRW	Released Forecast Spread	0,00 0,00 -	27,6 -43,4 163.52%	-47,7	-16,9	-39,1
EPS KRW	Released Forecast Spread	0,00 0,00 -	672 -1 402 147.89%	-1 473	-443	-967
Announcement Date		04/03/20	12/03/21	17/03/22	15/05/23	13/03/24

Fiscal Period	December	2023 Q3
Net sales Billions KRW	Released Forecast Spread	0,36
Announcement Date		15/11/23

2024-04-23 07:30 am	KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release
2024-04-23	INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23	SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23	SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-24 04:05 pm	VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24	JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24	BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24	PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24	REMEGEN CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24	HITGEN INC.: Q4 2023 Earnings Release

2024-04-17	BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-17	JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release
2024-04-12	SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release
2024-04-10 07:00 am	NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-08	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release
2024-04-02 03:06 am	TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release
2024-03-31	PEPTRON, INC.: Q4 2023 Earnings Release (Projected)
2024-03-31	BIONEER CORPORATION: Q4 2023 Earnings Release (Projected)
2024-03-29 08:30 am	INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release
2024-03-28	BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release